Quick Takeaways
- Jon Congleton has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $18,492,000.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jon Congleton
- Location
- Radnor, PA
- Summary
- The estimated net worth of Jon Congleton is at least $18,492,000 dollars as of 15 Apr 2026. Jon Congleton is the Chief Executive Officer, Director of Mineralys Therapeutics, Inc. and owns shares of Mineralys Therapeutics, Inc. (MLYS) stock worth about $18.49M.
- Signature
- /s/ Adam Levy, Attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jon Congleton and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Mineralys Therapeutics, Inc. ($18,492,000).
- Past-year value change for that position: -$12,885,397.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jon Congleton
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | Chief Executive Officer, Director | $18,492,000 | -$12,885,397 | -41% | 13 Apr 2026 |
| IMUX | IMMUNIC, INC. | Director | 27 Mar 2026 |
Insider Transactions Reported by Jon Congleton:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.